The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 27, 2009
Filed:
Nov. 03, 2004
Eric Connor, Los Gatos, CA (US);
Dominique Charmot, Campbell, CA (US);
Han-ting Chang, Livermore, CA (US);
Florence Roger, Preverenges, CH;
Gerrit Klaerner, Los Gatos, CA (US);
Son Hoai Nguyen, San Jose, CA (US);
Jonathan Mills, San Jose, CA (US);
Jerry M. Buysse, Los Altos, CA (US);
Angela Lee, San Jose, CA (US);
Deidre Madsen, Sunnyvale, CA (US);
Jun Shao, Fremont, CA (US);
Michael J. Cope, Berkeley, CA (US);
John Fordtran, Dallas, TX (US);
Eric Connor, Los Gatos, CA (US);
Dominique Charmot, Campbell, CA (US);
Han-Ting Chang, Livermore, CA (US);
Florence Roger, Preverenges, CH;
Gerrit Klaerner, Los Gatos, CA (US);
Son Hoai Nguyen, San Jose, CA (US);
Jonathan Mills, San Jose, CA (US);
Jerry M. Buysse, Los Altos, CA (US);
Angela Lee, San Jose, CA (US);
Deidre Madsen, Sunnyvale, CA (US);
Jun Shao, Fremont, CA (US);
Michael J. Cope, Berkeley, CA (US);
John Fordtran, Dallas, TX (US);
Ilypsa, Inc., Thousand Oaks, CA (US);
Abstract
Anion-binding polymers are described. The anion-binding polymers in some cases are low swelling anion-binding polymers. In some cases, the anion-binding polymers have a pore volume distribution such that a fraction of the polymer is not available for non-interacting solutes above a certain percentage of the MW of the target ion for the polymer. In some cases, the anion-binding polymers are characterized by low ion-binding interference, where the interference is measured in, for example, a gastrointestinal simulant, relative to non-interfering buffer. Pharmaceutical composition, methods of use, and kits are also described.